Sign in

Private company

Sinopharm

Logo: Sinopharm (company), Public domain, via Wikimedia Commons4

Chinese state-owned enterprise

China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise.3 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1998Founded1
  • Industrybiotechnology, biotechnology industry, medical technology industry, pharmaceutical industry1
  • HeadquartersBeijing1
  • Founded inBeijing1
  • Websitewww.sinopharm.com
  • Legal formpublic company1
  • Incorporated inNV5

See how the biggest companies compare on our leaderboards

Sinopharm Building (20230206145912)
Photo: N509FZ, CC BY-SA 4.0, via Wikimedia Commons7

China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group (SEHK: 1099, via a 51–49 joint venture, Sinopharm Industrial Investment, with Fosun Pharmaceutical), China Traditional Chinese Medicine (SEHK: 570, mostly via Sinopharm Group Hongkong Co., Ltd.), Shanghai Shyndec Pharmaceutical (SSE: 600420, via a wholly owned research institute based in Shanghai), and Beijing Tiantan Biological Products (SSE: 600161, via China National Biotec Group).3

Corporate structure

Sinopharm sits at the top of its group. 8 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

The story

Sinopharm was founded as China National Pharmaceutical Group Corporation (Chinese: 中国医药集团总公司) on November 26, 1998, as a holding company for China National Pharmaceutical Corporation, China National Pharmaceutical Industry Corporation (Chinese: 中国医药工业公司), China National Pharmaceutical Foreign Trade Corp. (Chinese: 中国医药对外贸易公司) and China National Medical Device (Chinese: 中国医疗器械工业公司). In 2009 it was merged with China National Biotec Group (Chinese: 中国生物技术集团公司).

Its subsidiary Wuhan Institute of Biological Products was fined for selling 400,520 ineffective DPT vaccines in November 2017.

Pfizer announced the signing of a cooperation pact with Sinopharm Group in April 2023, with plans to seek approval for 12 drugs in China through 2025.

From Wikipedia’s article on Sinopharm (company), shared under CC BY-SA 4.0.6

Products and brands

  • medication

Listed on Wikidata.1

Subsidiaries and ownership

Subsidiaries

From Wikidata.1

Timeline

  1. 1998Founded Founded in Beijing1

SEC filer profile

How Sinopharm is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARSINOPHARM INC2
  • CIK0001255764
  • Employer ID (EIN)98-03965402
  • Incorporated inNevada2
  • Fiscal year endsDecember 312
  • Industry code (SIC)2834 Pharmaceutical Preparations2
  • Mailing address152-11782 River Road, Richmond British Columbia, Canada V6X 1Z7, A1 000002
  • On EDGAR sinceDec 23, 20032
  • Filings8 in all: SB-2/A (7), SB-2 (1)2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7